AMRX vs GME · P/E 44, rev $1.52B vs P/E 16, rev $3.63B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus GameStop Corp. (GME) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
GameStop Corp. (GME) is a specialty retail company listed on US.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Not investment advice. Open the AMRX and GME stock pages for the full models.
Not investment advice.